Close Menu

NEW YORK (360Dx) – Accelerate Diagnostics said after the close of the market on Tuesday that its fourth quarter revenues decreased 17 percent year over year.

For the three months ended Dec. 31, 2018, the company posted revenues of $1.8 million compared to $2.1 million in revenues for Q4 2017. The Q4 revenues were in line with the company's preliminary figures announced last month but fell short of the consensus Wall Street estimate of $2.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.